Targeted therapies for MASH show progress, with pegozafermin leading in efficacy for fibrosis regression and disease resolution. The lack of head-to-head trials complicates treatment prioritization, ...

Medics from the 32nd Combat Support Hospital carry a mock patient on a litter from a UH-1 Iroquois helicopter to a Mobile Army Surgical Hospital (MASH) during the Reforger '82 exercise. (National ...

Panelists discuss how GLP-1 therapies show dual metabolic and hepatic benefits, redefining MASH management. Panelists discuss how GLP-1 receptor agonists, originally developed for diabetes and obesity ...

For years, food magazines have preached the many wonders of Yukon Gold potatoes. They told us Golds were the superior spud—the only potato worth mashing. They made us feel like a fool for even ...

I often love Ina Garten's easy, flavorful recipes, so I gave her buttermilk mashed potatoes a try. The buttermilk made this dish more flavorful than other mashed-potato recipes I've followed. From now ...

Julia Child was a longtime Food & Wine contributor, a household name, and a champion of French cuisine. She authored Mastering the Art of French Cooking, a world-renowned tome with more than 500 ...

EXCLUSIVE: The 1962 song “Monster Mash,” which has become an annual Halloween +hit, is becoming an animated movie at Miramax. Miramax CEO Jonathan Glickman, who has been behind such haunted hits as ...

For years, MASH was where drug development dreams went to die. One trial after another failed. Companies bowed out. The field earned a reputation as one of biopharma’s most intractable challenges: a ...

Metabolic-associated steatohepatitis (MASH) happens when excess fat in the liver causes inflammation and scarring, or fibrosis. The condition is serious, and when left untreated it can lead to ...

Note: The U.S. Food and Drug Administration (FDA) doesn’t approve supplements for safety or effectiveness. Always talk with your healthcare professional about whether a supplement fits your health ...

Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...